Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.
Dantari has raised $47.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
Dantari's investors include Westlake Village BioPartners, Alexandria Venture Investments, Corner Ventures, Caltech.
Dantari is headquartered in Thousand Oaks, United States.
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.
Dantari is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dantari — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/dantari. Accessed November 11, 2026.
VCBacked. (2022). Dantari — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/dantari
{{cite web |title=Dantari — Funding & Investors |url=https://www.vcbacked.co/company/dantari |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Dantari? Request a listing update